Lord, Abbett & Co
AZN icon

Lord, Abbett & Co’s AstraZeneca AZN Stock Holding History

Lord, Abbett & Co’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Buy
64,127
+6,456
+11% +$1.21M 0.03% 360
2026
Q1 		$11.2M Buy
+57,671
New +$11.1M 0.04% 345
2022
Q4 		– Sell
-477,065
Closed -$52.3M – 576
2022
Q3 		$52.3M Sell
477,065
-195,477
-29% -$24.8M 0.19% 146
2022
Q2 		$88.9M Buy
+672,542
New +$88.2M 0.31% 87
2022
Q1 		– Sell
-15,237
Closed -$1.77M – 607
2021
Q4 		$1.77M Buy
15,237
+434
+3% +$51.1K ﹤0.01% 589
2021
Q3 		$1.78M Sell
14,803
-82
-0.6% -$9.54K ﹤0.01% 619
2021
Q2 		$1.78M Buy
14,885
+4,675
+46% +$513K ﹤0.01% 634
2021
Q1 		$1.01M Sell
10,210
-679,440
-99% -$68.3M ﹤0.01% 620
2020
Q4 		$69M Sell
689,650
-155,418
-18% -$16.5M 0.18% 178
2020
Q3 		$92.6M Buy
845,068
+205,504
+32% +$22.9M 0.3% 103
2020
Q2 		$67.7M Buy
639,564
+626,132
+4,661% +$64.7M 0.24% 123
2020
Q1 		$1.2M Buy
+13,432
New +$1.26M 0.01% 607
2015
Q2 		– Sell
-44,897
Closed -$3.07M – 923
2015
Q1 		$3.07M Buy
44,897
+687
+2% +$47.7K 0.01% 805
2014
Q4 		$3.11M Buy
44,210
+1,832
+4% +$131K 0.01% 807
2014
Q3 		$3.03M Buy
+42,378
New +$3.1M 0.01% 829

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lord, Abbett & Co's AZN Position: Q2 2026 in Review

Lord, Abbett & Co increased its AstraZeneca (AZN) stake by 11% in Q2 2026, buying an estimated $1.21M and bringing the position to 64,127 shares worth $12M. The position accounts for 0.03% of the portfolio, ranked #360.

Lord, Abbett & Co first reported a position in AZN in Q3 2014 and has held it in 15 quarters since. The position peaked at $92.6M in Q3 2020. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Lord, Abbett & Co held 64,127 shares of AstraZeneca worth $12M as of Q2 2026.
  • Lord, Abbett & Co bought 6,456 AstraZeneca shares in Q2 2026, an estimated $1.21M.
  • AstraZeneca made up 0.03% of Lord, Abbett & Co's portfolio in Q2 2026, its #360 holding.
  • Lord, Abbett & Co first reported a position in AstraZeneca in Q3 2014 and has held it in 15 quarters since.
  • Lord, Abbett & Co's AstraZeneca position peaked at $92.6M in Q3 2020.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.